- Citations, last 5 years
- 122.6k
- Works, last 5 years
- 18.9k
- h-index
- 824
- Scientists listed
- 0
- Grants since 2016
- 1 725
Grants received
2021–2026 · cooperative agreement · UG1
Thomas Jefferson University Hospital Clinical Site for HEAL NOWS Pharmacologic Trial
Susan Adeniyi-Jones · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
Edward Castillo · Thomas Jefferson University · funded by National Institutes of Health
2021–2023 · cooperative agreement · UG3
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy
Edward Castillo · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of cell death in cutaneous melanoma
Emad S Alnemri · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Tissue Damage-Driven Squamous Cell Carcinoma
Andrew South · Thomas Jefferson University · funded by National Institutes of Health
2021–2023 · cooperative agreement · UG1
Thomas Jefferson University Hospital Clinical Site for HEAL NOWS Pharmacologic Trial
Susan Adeniyi-Jones · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
Edward Castillo · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
Ross S Summer · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R35
Mechanism of Viral Genome Delivery into Cells
Gino Cingolani · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer
William K. Kelly · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of cell death in cutaneous melanoma
Emad S Alnemri · Thomas Jefferson University · funded by National Institutes of Health
2021–2023 · research · R21
Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations
Luis J Sigal · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R35
Mechanism of Viral Genome Delivery into Cells
Gino Cingolani · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection
Hee-Soon Juon · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer
William K. Kelly · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · grant · OCRP
New Approach to Targeting Serous Ovarian Cancer
Christine Eischen · Thomas Jefferson University · funded by Congressionally Directed Medical Research Programs
2021–2023 · research · R35
Mechanism of Viral Genome Delivery into Cells
Gino Cingolani · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation
Jianxin Sun · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
Gyorgy Csordas · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Regulation of Mutationally Activated Gq/11
Philip B Wedegaertner · Thomas Jefferson University · funded by National Institutes of Health
2021–2024 · research · R01
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
Ross S Summer · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease
Gyorgy Csordas · Thomas Jefferson University · funded by National Institutes of Health
2021–2023 · research · R21
Pharmacologic Intervention for Ectopic Calcification
Qiaoli Li · Thomas Jefferson University · funded by National Institutes of Health
2021–2023 · research · R35
Mechanism of Viral Genome Delivery into Cells
Gino Cingolani · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
Bruno Calabretta · Thomas Jefferson University · funded by National Institutes of Health
2021–2023 · research · R21
A System to Study Salmonella Typhi Infection and Immunity
Kishore R Alugupalli · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Critical Role of Small Extracellular Vesicles in Diabetic Coronary Vascular Dysfunction and Diabetic Ischemic Heart Failure efforts.
Yajing Wang · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · cooperative agreement · UH3
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy
Edward Castillo · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
Bruno Calabretta · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R00
Molecular mechanisms of Werner syndrome helicase in genome stability and aging
Michael Soniat · Thomas Jefferson University · funded by National Institutes of Health
2021–2022 · research · R21
Synergistic Interactions of SARs-CoV2 and environmental toxicants in Experimental Parkinsonism
Richard J Smeyne · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
TrmD-targeting actinobacterial natural products as next generation antibiotics
Ya-Ming Hou · Thomas Jefferson University · funded by National Institutes of Health
2021–2024 · fellowship · F30
Silencing the uroguanylin-GUCY2C gut-brain axis mediates leptin resistance in obesity
Joshua R Barton · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS
Lin Guo · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Mitochondrial translocator protein: a target for bronchodilation
Ajay Nayak · Thomas Jefferson University · funded by National Institutes of Health
2021–2026 · research · R01
Molecular mechanisms of triplet repeat instability in Huntington's disease
Anna Pluciennik · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection
Hee-Soon Juon · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
Ross S Summer · Thomas Jefferson University · funded by National Institutes of Health
2021–2023 · fellowship · F31
Regulation of Development by LRP4 at Drosophila Peripheral Synapses
Alison Depew · Thomas Jefferson University · funded by National Institutes of Health
2021–2025 · research · R01
Tissue Damage-Driven Squamous Cell Carcinoma
Andrew South · Thomas Jefferson University · funded by National Institutes of Health